Detalhe da pesquisa
1.
Live, Attenuated, Tetravalent Butantan-Dengue Vaccine in Children and Adults.
N Engl J Med
; 390(5): 397-408, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38294972
2.
Translational success of fundamental virology: a VSV-vectored Ebola vaccine.
J Virol
; 98(3): e0162723, 2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38305150
3.
Immunogenicity and Vaccine Shedding After 1 or 2 Doses of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO®): Results From a Phase 2, Randomized, Placebo-controlled Trial in Children and Adults.
Clin Infect Dis
; 78(4): 870-879, 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37967326
4.
Immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine (ERVEBO®) in African clinical trial participants by age, sex, and baseline GP-ELISA titer: A post hoc analysis of three Phase 2/3 trials.
Vaccine
; 40(46): 6599-6606, 2022 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36208978
5.
A phase I randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and immunogenicity of a live-attenuated quadrivalent dengue vaccine in flavivirus-naïve and flavivirus-experienced healthy adults.
Hum Vaccin Immunother
; 18(5): 2046960, 2022 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35290152
6.
Lessons Learned from the Development and Roll-Out of the rVSVΔG-ZEBOV-GP Zaire ebolavirus Vaccine to Inform Marburg Virus and Sudan ebolavirus Vaccines.
Vaccines (Basel)
; 10(9)2022 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36146524
7.
Environmental Risk Assessment for rVSVΔG-ZEBOV-GP, a Genetically Modified Live Vaccine for Ebola Virus Disease.
Vaccines (Basel)
; 8(4)2020 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33352786
8.
Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants.
Vaccine
; 36(45): 6883-6891, 2018 10 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-30244873
9.
Clinical development of a recombinant Ebola vaccine in the midst of an unprecedented epidemic.
Vaccine
; 35(35 Pt A): 4465-4469, 2017 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-28647166
10.
Advances in the understanding, management, and prevention of dengue.
J Clin Virol
; 64: 153-9, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25453329
11.
Preclinical development of a dengue tetravalent recombinant subunit vaccine: Immunogenicity and protective efficacy in nonhuman primates.
Vaccine
; 33(33): 4105-16, 2015 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26144900
12.
Preclinical and clinical development of a dengue recombinant subunit vaccine.
Vaccine
; 33(50): 7126-34, 2015 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26458804
13.
Dengue vaccines: progress and challenges.
Curr Opin Immunol
; 23(3): 391-8, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21514129
14.
The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced disease.
Vaccine
; 29(42): 7267-75, 2011 Sep 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-21777637
15.
Advances in flavivirus vaccine development.
IDrugs
; 13(12): 880-4, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21154147
16.
Development of a recombinant tetravalent dengue virus vaccine: immunogenicity and efficacy studies in mice and monkeys.
Vaccine
; 28(15): 2705-15, 2010 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-20097152